The cumulative use of strong anticholinergics is associated with an increased risk for dementia in a dose-response pattern; ...

The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...

Medication treatment for COPD usually involves inhaled medications, such as beta agonists like albuterol or long-acting forms ...

Medication treatment for COPD usually involves inhaled medications, such as beta agonists like albuterol or long-acting forms ...

Medication treatment for COPD usually involves inhaled medications, such as beta agonists like albuterol or long-acting forms ...

MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced the ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

The results were eye-opening. Those taking at least one anticholinergic drug had a 47% higher chance of developing mild ...

After over 50 years of smoking, my wife has chronic obstructive pulmonary disease (COPD) and bad scarring of her lungs, but fortunately she doesn’t have cancer. She had respiratory syncytial virus ...

The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...

Neuropsychiatric disorder specialist MapLight Therapeutics has made its debut on the Nasdaq, raising $251 million and arriving on the scene valued somewhere north of $800 million.